Regulatory Webinars
-
Operationalizing Adaptive Design For FDA's One-Trial Era
10/20/2026
The FDA now accepts one pivotal trial as the default path to approval. Learn how adaptive designs can help you build a single study strong enough to stand on its own.
-
Cast A Clinical Trial Disclosure 'Net,' Not A 'Line'
10/13/2026
In clinical trial disclosure, each country’s obligations are typically treated as separate, isolated tasks. This approach may appear efficient on the surface but can introduce major compliance risks.
-
Scaling Pharmacovigilance: Clinical Development To Commercialization
10/1/2026
Commercial growth brings new PV challenges. Gain practical insights on operating models, technology, governance, and leadership for long-term success.
-
The Future Of Clinical Trials: AI, Real-Time Data, And FDA Innovation
9/30/2026
How does building trial protocols into health records lets key safety and efficacy signals reach sponsors and regulators in days, cutting manual data entry and speeding decisions.
-
Cell & Gene Unscripted: Regulatory Affairs
9/17/2026
One platform, multiple payloads: how delivery systems can lower costs and boost access. Parexel experts break down the regulatory data that matters on Cell & Gene Unscripted.
-
Cell & Gene Unscripted: Pre-Clinical
9/17/2026
Regulatory modernization is progressing, but harmonization gaps remain. Parexel's Chris Learn & Liz Spehalski dive into pre-IND strategy and precision therapies on Cell & Gene Unscripted.
-
The Evidence Gap In Hematology: From Trial Endpoints To Patient Outcomes
9/16/2026
Hematology trials face shrinking patient pools and fierce competition. Discover how real-world data and evidence can sharpen feasibility, site selection, and regulatory strategy.
-
A New Chapter for Orexin Therapies: What's Changing in Drug Development
9/16/2026
Join Beatrice Setnik, PhD and Denise Milova, PhD, for a conversation on orexin rescheduling and the evolving regulatory landscape.
-
Protocol Builder And Informed Consent Builder Version 2.0
9/16/2026
Built by research compliance experts, this platform streamlines the protocol-writing process through customizable templates, workflow tools, and collaboration support for research teams.
-
Protocol Design Choices That Trigger IRB And Regulatory Requirements
8/20/2026
Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.